Stanford University
Showing 5,501-5,550 of 34,871 Results
-
Jen-Fei Chu
Graduate, Stanford Center for Professional Development
BioDr. Chu is an experienced postdoctoral researcher who has built a strong track record at Academia Sinica, Taiwan. He completed his Ph.D. in Biophysics and Physical Chemistry at the Institute of Atomic and Molecular Sciences (IAMS), gaining expertise in single-molecule imaging, molecular mechanisms, and data analysis. He then applied these imaging skills to neuroscience research at the Institute of Molecular Biology (IMB), with a focus on autism spectrum disorder (ASD) and amyotrophic lateral sclerosis (ALS).
Beyond his rigorous research, Dr. Chu studied law at National Taiwan University (NTU) in preparation for the bar examination. He is now taking credit-bearing graduate courses in electrical engineering and AI at Stanford University through the Center for Global and Online Education (CGOE), working toward the advanced degrees. -
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.
For a full description of my educational informatics work, please see my website aim.stanford.edu.
My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.
I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.
The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain. -
Steven Chu
William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering
Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioAlex Weihan Chu, M.D. serves as a Clinical Assistant Professor at Stanford School of Medicine and is the Associate Chief Medical Officer and Vice President of Quality, Health Equity, and Clinical Affairs at Stanford Health Care Tri-Valley.
Dr. Chu has been a dedicated member of SHC Tri-Valley since 2015, joining as a Hospital Medicine physician after completing his residency at Stanford Hospital. He is board-certified in Internal Medicine and Clinical Informatics. Since 2016, he has served as the Medical Informatics Director, a role he continues to oversee, ensuring that technology enhances clinical workflows and patient care.
Dr. Chu has held multiple leadership roles, including serving on the Medical Executive Committee and as Vice Chief of Medicine. He previously served as Associate Chief Medical Officer for Patient Safety, Infection Control & Accreditation, Regulatory & Licensing, where he played a key role in supporting Joint Commission surveys, ensuring CDPH compliance, and leading hospital safety initiatives to address regulatory findings.
In 2024, Dr. Chu transitioned to his current role, the Associate Chief Medical Officer and Vice President for Quality, Health Equity, and Clinical Affairs where he is responsible for coordinating a comprehensive system of quality monitoring and improvement to achieve excellent patient care. He works closely with Kathleen Carrothers, Senior Director of Quality Management and Performance Improvement, to oversee clinical outcomes, data management, and performance improvement initiatives. He also leads health equity efforts and manages physician agreements, ensuring sustained high-quality care and strategic physician engagement.
Dr. Chu brings expertise in physician engagement, clinical oversight, clinical informatics, and quality improvement. His experience in driving multi-disciplinary change and advancing health equity to aligns with the hospital’s mission and vision.
Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring the latest advancements in technology. -
Ian Chua
Clinical Associate Professor, Pediatrics
BioIan Chua, MD, MHPE, MBA is a bicoastal pediatric hospitalist and clinical associate professor of pediatrics at Stanford Children’s Health (Palo Alto, CA) and Children’s National Medical Center (Washington, DC). He completed his residency at Stanford Children’s with concentrations in medical education and quality improvement. He obtained his Masters’ in Health Professions Education at University of Illinois in Chicago. He currently co-directs the Quality and Leadership Training (QUILT) program in the department of pediatrics as well as the PHM Leadership Rotation. He also directs the ACGME Fellows’ Common Core Curriculum, the PHM Fellowship Medical Education Pathway, and the Pediatric residency medical education pathway at Children’s National Medical Center. His interests have been in educational scholarship and professional development of transitional learners including junior faculty. Nationally, he has been involved in shaping the national PHM fellows' conference and is the current co-chair for the AAP SOHM Emerging Leaders Conference.
-
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
-
Mei-Sze Chua
Sr Res Scientist-Basic Ls, Surgery - General Surgery
Current Role at StanfordI spearhead multiple projects stemming from the lab’s initial genomics study on liver cancer, with the goal of translating gene expression data of liver cancer patients into improved clinical approaches for the diagnosis and therapy of this fatal disease. I have successfully led inter-disciplinary projects, mentored postdoctoral fellows and visiting scientists, and effectively worked with diverse groups of collaborators from academic and industrial settings. I am committed to help eliminate global health care burden associated with hepatitis B and liver cancer.
-
Cynthia Chuang
Clinical Professor, Radiation Oncology - Radiation Physics
BioEducation:
1990-B.S., Bioelectrical Engineering (6-1B), Massachusetts Institute of Technology, Cambridge, MA
1992-M.S., Bioengineering, University of Pennsylvania, Philadelphia, PA
1994-M.S., Nuclear Engineering (NMR Spectroscopy), Massachusetts Institute of Technology, Cambridge, MA
1999-Ph.D., Nuclear Engineering (Boron Neutron Capture Therapy), Massachusetts Institute of Technology, Cambridge, MA
2001-Postdoctoral Fellowship (Peregrine Project), Lawrence Livermore National Laboratory
2003-Medical Physics Residency, University of California, San Francisco (joint 3.5-year postdoctoral and residency program)
Academic Appointments:
2003 - 2005-Clinical Instructor, Radiation Oncology, University of California, San Francisco, San Francisco, California
2005 - 2009-Assistant Adjunct Professor, Radiation Oncology, University of California, San Francisco, San Francisco, California
2009 - 2013-Assistant Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California
2013 - 2017-Associate Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California
2017 - 2018-Associate Professor of Clinical Radiation Oncology, University of California, San Francisco, San Francisco, California
2019 - 2023-Clinical Associate Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA
2023- Present-Clinical Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA -
Henry Chubb
Clinical Associate Professor, Pediatrics - Cardiology
Current Research and Scholarly Interestshttps://www.researchgate.net/profile/Henry_Chubb
-
William Chueh
Director, Precourt Institute for Energy, Kimmelman Professor, Professor of Materials Science and Engineering, of Energy Science and Engineering, of Photon Science and Senior Fellow at the Precourt Institute for Energy
BioThe availability of low-cost but intermittent renewable electricity (e.g., derived from solar and wind) underscores the grand challenge to store and dispatch energy so that it is available when and where it is needed. Redox-active materials promise the efficient transformation between electrical, chemical, and thermal energy, and are at the heart of carbon-neutral energy cycles. Understanding design rules that govern materials chemistry and architecture holds the key towards rationally optimizing technologies such as batteries, fuel cells, electrolyzers, and novel thermodynamic cycles. Electrochemical and chemical reactions involved in these technologies span diverse length and time scales, ranging from Ångströms to meters and from picoseconds to years. As such, establishing a unified, predictive framework has been a major challenge. The central question unifying our research is: “can we understand and engineer redox reactions at the levels of electrons, ions, molecules, particles and devices using a bottom-up approach?” Our approach integrates novel synthesis, fabrication, characterization, modeling and analytics to understand molecular pathways and interfacial structure, and to bridge fundamentals to energy storage and conversion technologies by establishing new design rules.
-
Hayson Chui
Affiliate, IT Services
BioHayson Chui, PA-C is an APP fellow at Stanford Health Care training in the field of cardiothoracic surgery. He graduated with his B.S. in Psychobiology from the University of California, Los Angeles in 2020 and his Master of Science in Physician Assistant (PA) Studies from Southern California University of Health Sciences in 2024. His area of clinical practice is in cardiothoracic surgery, primarily specializing in surgical interventions for cardiac and pulmonary disorders.
